Latest Breaking News On - Difficult targets - Page 1 : comparemela.com

/PRNewswire/ PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced its participation in the Antibody Engineering & Therapeutics.

Noord hollandFrancois romagneAix marseille universityPhenomex incPostillion hotel amsterdamBeacon single cell technologyPrnewswire phenomex incBeacon selectAntibody engineeringPostillion hotelAix marseilleAntibody discoveryDifficult targetsBeacon single cell